These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 351593)

  • 21. Long-term treatment of hypertension with methyldopa. IV. Duration of methyldopa therapy.
    del Greco F; Huang CM; Quintanilla A
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S99-103. PubMed ID: 6172673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Methyldopa: study of the antihypertensive and renin-reducing effects at rest and after exercise].
    Sbissa AS; Sbissa LA; Thiesen AL; Zunino JN
    Arq Bras Cardiol; 1981 Sep; 37(3):213-7. PubMed ID: 7052027
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.
    Mroczek WJ; Fotiu S; Davidov ME; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):769-77. PubMed ID: 4217243
    [No Abstract]   [Full Text] [Related]  

  • 26. Double-blind studies of the clinical effectiveness of prazosin.
    Schnaper HW; Oberman A
    Postgrad Med; 1975 Nov; Spec No():81-7. PubMed ID: 1105489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL; Davies DM; Gales GM; Rao JG; Rawlins MD; Routledge PA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of prazosin as the sole agent for the treatment of hypertension: a double-blind cross-over study with methyldopa.
    Bloom DS; Rosendorff C; Kramer R
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):144-50. PubMed ID: 809230
    [No Abstract]   [Full Text] [Related]  

  • 30. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
    Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term treatment of hypertension with methyldopa. III. Tolerability.
    Caldwell JR; Metts JC
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S92-8. PubMed ID: 6172672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alprenolol and alphamethyl-dopa in untreated cases of essential hypertension--a comparison].
    Bergstrand RH; Vedin JA; Wilhelmsson CE
    Lakartidningen; 1973 Aug; 70(33):2817-20. PubMed ID: 4597664
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative clinical experimental studies with pure alpha-methyldopa and in combination with hydrochlorothiazide].
    Fiegel G; Bargheer R; Heindorf M
    Wien Klin Wochenschr; 1965 Jun; 77(25):470-2. PubMed ID: 5319350
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prazosin and methyldopa in hypertension.
    Nanivadekar AS; Kulkarni SS
    Practitioner; 1981 Sep; 225(1359):1327-9. PubMed ID: 7031634
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the antihypertensive action of methyldopa alone or in combination with hydrochlorothiazide].
    Mattar E; Cruz HM; Cruz J
    Rev Paul Med; 1971 Jul; 78(1):19-30. PubMed ID: 5164628
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term treatment of hypertension with methyldopa. I. Study objectives and design.
    Itskovitz HD; Menduke H
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S79-84. PubMed ID: 6172670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical trial of alpha-methyldopa (Aldomet) and hydrochlorthiazide (Dichlotride) alone and in combination in hypertension.
    Vaidya PM; Munshi CP; Sawkar LA; Parikh HM; Gulati OD
    Indian J Physiol Pharmacol; 1971 Jan; 15(1):35-41. PubMed ID: 4941549
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative antihypertensive effects of guanabenz and methyldopa.
    Walker BR; Deitch MW; Schneider BE; Hare LE
    Clin Ther; 1981; 4(4):275-84. PubMed ID: 7332915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.